Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary arterial hypertension in a US Medicare population: a retrospective database analysis

Limited evidence is available on outcomes associated with currently available medications from the endothelin receptor antagonist drug class (bosentan, ambrisentan, and macitentan) in elderly patients with pulmonary arterial hypertension. We evaluated mortality in predominantly elderly patients with...

Full description

Bibliographic Details
Main Authors: Raymond L. Benza, Cassandra A. Lickert, Lin Xie, William Drake, Adesuwa Ogbomo, Huseyin Yuce, Michele R. Cole
Format: Article
Language:English
Published: SAGE Publishing 2020-10-01
Series:Pulmonary Circulation
Online Access:https://doi.org/10.1177/2045894020954158